News Detail

New Delhi, 29 June 2023: The Drugs Technical Advisory Board (DTAB) has refused to revoke the prohibition on the use of the fixed dose combination (FDC) of vitamin B1, B6 and B12, as against a representation from a multinational pharmaceutical company in the country, noting that t......
View Details
Source : Pharmabiz
DTAB
revoke
prohibition
FDC
vitamin B1
vitamin B6
vitamin B12
CDSCO
P&G
carpal tunnel syndrome
alcohol abuse
autoimmune diseases
rheumatoid arthritis
chronic inflammation
neurotrophic
DCGI
Related News
- Gujarat FDCA attributes 45% of drug samples failing quality tests due to dissolution testing (25-09-2023)
- CDSCO says samples labelled as Cipla's and Sun Pharma's drugs failed in July could be spurious (25-09-2023)
- Govt in process of identifying additional regulatory interventions to stop Misuse of Antimicrobials (25-09-2023)
- Resistance to last-resort antibiotics Carbapenem growing in India: ICMR report (25-09-2023)
- 4 arrested with 375 bottles of Eskuf cough syrup worth Rs 4 lakh (25-09-2023)
- Ghaziabad: Fake Augmentin 625 Duo and Ultracet worth Rs 8 lakh seized, four arrested (24-09-2023)
- Police recovered 292 intoxicating capsules and 5760 pills in Ambala (24-09-2023)
- One Arrested by Cachar Police with 18,000 Yaba Tablets (24-09-2023)
- Indian-origin girl receives first rejection-free kidney from mother in UK (24-09-2023)
- 3D-printed medical devices gain ground (24-09-2023)